Huntington National Bank decreased its position in HCP, Inc. (NYSE:HCP) by 5.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20,713 shares of the real estate investment trust’s stock after selling 1,180 shares during the period. Huntington National Bank’s holdings in HCP were worth $663,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of HCP. Deutsche Bank AG lifted its stake in shares of HCP by 1,073.7% in the fourth quarter. Deutsche Bank AG now owns 10,704,554 shares of the real estate investment trust’s stock valued at $298,971,000 after purchasing an additional 9,792,507 shares during the period. Norges Bank acquired a new stake in shares of HCP in the fourth quarter valued at about $128,473,000. Janus Henderson Group PLC lifted its stake in shares of HCP by 174.6% in the first quarter. Janus Henderson Group PLC now owns 4,260,860 shares of the real estate investment trust’s stock valued at $133,376,000 after purchasing an additional 2,709,368 shares during the period. Duff & Phelps Investment Management Co. acquired a new stake in shares of HCP in the first quarter valued at about $81,652,000. Finally, Unigestion Holding SA lifted its stake in shares of HCP by 1,639.7% in the second quarter. Unigestion Holding SA now owns 2,016,300 shares of the real estate investment trust’s stock valued at $64,481,000 after purchasing an additional 1,900,400 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

HCP traded up $0.12 during midday trading on Tuesday, reaching $32.20. 75,820 shares of the company’s stock were exchanged, compared to its average volume of 1,970,071. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.90. The firm has a market cap of $15.36 billion, a PE ratio of 17.66, a PEG ratio of 6.97 and a beta of 0.31. The company’s 50-day moving average price is $32.26. HCP, Inc. has a 1-year low of $24.47 and a 1-year high of $33.58.

HCP (NYSE:HCP) last announced its earnings results on Wednesday, May 1st. The real estate investment trust reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.01. The company had revenue of $436.15 million during the quarter, compared to analysts’ expectations of $442.20 million. HCP had a net margin of 59.96% and a return on equity of 18.05%. The firm’s quarterly revenue was down 9.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.48 earnings per share. Equities analysts predict that HCP, Inc. will post 1.74 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 20th. Stockholders of record on Monday, August 5th will be given a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a dividend yield of 4.60%. The ex-dividend date is Friday, August 2nd. HCP’s dividend payout ratio is presently 81.32%.

HCP has been the subject of several recent analyst reports. KeyCorp cut shares of GTT Communications from an “overweight” rating to a “sector weight” rating in a research note on Monday, July 1st. Raymond James initiated coverage on shares of Adverum Biotechnologies in a research note on Thursday, June 13th. They issued a “market perform” rating for the company. Finally, TheStreet upgraded shares of Rent-A-Center from a “c” rating to a “b-” rating in a research note on Tuesday, May 7th. Three equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $30.70.

In other news, Director Christine Garvey sold 3,405 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $29.80, for a total value of $101,469.00. Following the completion of the transaction, the director now owns 5,348 shares of the company’s stock, valued at $159,370.40. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.13% of the company’s stock.

HCP Company Profile

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Featured Story: Cost of Goods Sold (COGS)

Want to see what other hedge funds are holding HCP? Visit to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with's FREE daily email newsletter.